Vaughan David Investments LLC IL Buys 368 Shares of The Allstate Co. (NYSE:ALL)

Vaughan David Investments LLC IL boosted its stake in shares of The Allstate Co. (NYSE:ALLFree Report) by 0.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 272,858 shares of the insurance provider’s stock after acquiring an additional 368 shares during the period. Allstate accounts for about 1.2% of Vaughan David Investments LLC IL’s portfolio, making the stock its 19th biggest position. Vaughan David Investments LLC IL owned about 0.10% of Allstate worth $52,604,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently modified their holdings of ALL. Allworth Financial LP lifted its position in shares of Allstate by 1.5% in the 3rd quarter. Allworth Financial LP now owns 14,584 shares of the insurance provider’s stock worth $2,766,000 after purchasing an additional 213 shares during the period. Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of Allstate by 24.2% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 16,397 shares of the insurance provider’s stock valued at $3,089,000 after buying an additional 3,200 shares in the last quarter. Arkadios Wealth Advisors lifted its position in shares of Allstate by 15.5% during the third quarter. Arkadios Wealth Advisors now owns 5,228 shares of the insurance provider’s stock valued at $991,000 after purchasing an additional 701 shares in the last quarter. PFG Investments LLC lifted its position in shares of Allstate by 4.1% during the third quarter. PFG Investments LLC now owns 5,805 shares of the insurance provider’s stock valued at $1,101,000 after purchasing an additional 228 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC lifted its position in shares of Allstate by 39.0% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 97,170 shares of the insurance provider’s stock valued at $18,428,000 after purchasing an additional 27,253 shares in the last quarter. Institutional investors and hedge funds own 76.47% of the company’s stock.

Allstate Price Performance

ALL opened at $188.60 on Tuesday. The Allstate Co. has a 1 year low of $153.87 and a 1 year high of $209.88. The firm has a market capitalization of $49.94 billion, a PE ratio of 11.10, a price-to-earnings-growth ratio of 1.01 and a beta of 0.52. The company has a debt-to-equity ratio of 0.42, a current ratio of 0.36 and a quick ratio of 0.40. The business’s 50-day moving average is $190.12 and its two-hundred day moving average is $190.56.

Allstate (NYSE:ALLGet Free Report) last released its earnings results on Wednesday, February 5th. The insurance provider reported $7.67 EPS for the quarter, topping analysts’ consensus estimates of $5.40 by $2.27. Allstate had a return on equity of 28.20% and a net margin of 7.28%. Research analysts anticipate that The Allstate Co. will post 18.74 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on ALL shares. Wells Fargo & Company lifted their target price on shares of Allstate from $186.00 to $187.00 and gave the stock an “equal weight” rating in a research note on Tuesday, January 14th. Barclays dropped their target price on shares of Allstate from $187.00 to $183.00 and set an “underweight” rating for the company in a research report on Monday, January 6th. Evercore ISI upgraded shares of Allstate from an “in-line” rating to an “outperform” rating in a research report on Wednesday, January 8th. Keefe, Bruyette & Woods boosted their price objective on shares of Allstate from $235.00 to $240.00 and gave the stock an “outperform” rating in a report on Tuesday, February 11th. Finally, Piper Sandler lifted their target price on shares of Allstate from $206.00 to $244.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 26th. One research analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $217.94.

Check Out Our Latest Report on Allstate

Insider Activity

In other news, CFO Jesse E. Merten sold 40,102 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $186.53, for a total value of $7,480,226.06. Following the completion of the sale, the chief financial officer now directly owns 18,115 shares in the company, valued at $3,378,990.95. The trade was a 68.88 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 1.80% of the company’s stock.

Allstate Profile

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Featured Stories

Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALLFree Report).

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.